![]() |
Volumn 16, Issue 1, 2002, Pages 30-35
|
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
a a a a a a a |
Author keywords
B CLL; CD38; Prognostic marker
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
CD38 ANTIGEN;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
B CELL LEUKEMIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CELL SURFACE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL FEATURE;
COHORT ANALYSIS;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG RESPONSE;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
LABORATORY TEST;
MAJOR CLINICAL STUDY;
MALE;
PATIENT CODING;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
ADP-RIBOSYL CYCLASE;
ANTIGENS, CD;
ANTIGENS, CD38;
ANTIGENS, DIFFERENTIATION;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
B-LYMPHOCYTES;
COHORT STUDIES;
FEMALE;
HEMOGLOBINS;
HUMANS;
IMMUNOGLOBULIN A;
IMMUNOPHENOTYPING;
LEUKEMIA, B-CELL, CHRONIC;
LIFE TABLES;
MALE;
MEMBRANE GLYCOPROTEINS;
MIDDLE AGED;
NAD+ NUCLEOSIDASE;
PLATELET COUNT;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
RISK FACTORS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TUMOR STEM CELLS;
|
EID: 85009914892
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402339 Document Type: Article |
Times cited : (205)
|
References (18)
|